Advanced search
Publication Cover
Expert Review of Endocrinology & Metabolism Volume 4, 2009 - Issue 2
Submit an article Journal homepage
426
Views
2
CrossRef citations to date
0
Altmetric
Editorial

Unraveling the mechanisms linking obesity and heart failure: the role of adipokines

Gary Sweeney Department of Biology, York University, Toronto, M3J 1P3, ON, Canada and Institut Pasteur Korea, 39–1 Hawolgok-dong, Seongbuk-gu, Seoul, 136–791, Korea. [email protected]; [email protected]
Pages 95-97 | Published online: 10 Jan 2014

References

  • Abel ED, Litwin SE, Sweeney G. Cardiac remodeling in obesity. Physiol. Rev.88(2), 389–419 (2008).
  • Artham SM, Lavie CJ, Milani RV, Ventura HO. The obesity paradox: impact of obesity on the prevalence and prognosis of cardiovascular diseases. Postgrad. Med.120(2), 34–41 (2008).
  • Mathieu P, Pibarot P, Larose E, Poirier P, Marette A, Despres JP. Visceral obesity and the heart. Int. J. Biochem. Cell Biol.40(5), 821–836 (2008).
  • Gupta S, Sen S. Animal models for heart failure. Methods Mol. Med.129, 97–114 (2006).
  • Gualillo O, Gonzalez-Juanatey JR, Lago F. The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives. Trends Cardiovasc. Med.17(8), 275–283 (2007).
  • Rabkin SW. Epicardial fat: properties, function and relationship to obesity. Obes. Rev.8(3), 253–261 (2007).
  • Skurk C, Wittchen F, Suckau L et al. Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy. Eur. Heart J.29(9), 1168–1180 (2008).
  • Do D, Alvarez J, Chiquette E, Chilton R. The good fat hormone: adiponectin and cardiovascular disease. Curr. Atheroscler. Rep.8(2), 94–99 (2006).
  • Hopkins TA, Ouchi N, Shibata R, Walsh K. Adiponectin actions in the cardiovascular system. Cardiovasc. Res.74(1), 11–18 (2007).
  • Ouchi N, Shibata R, Walsh K. Targeting adiponectin for cardioprotection. Expert Opin. Ther. Targets10(4), 573–581 (2006).
  • Fang X, Sweeney G. Mechanisms regulating energy metabolism by adiponectin in obesity and diabetes. Biochem. Soc. Trans.34(Pt 5), 798–801 (2006).
  • Schram K, Sweeney G. Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure. Trends Cardiovasc. Med.18, 199–205 (2008).
  • Abel ED. Myocardial insulin resistance and cardiac complications of diabetes. Curr. Drug Targets Immune Endocr. Metabol. Disord.5(2), 219–226 (2005).
  • Kintscher U. Does adiponectin resistance exist in chronic heart failure? Eur. Heart J.28(14), 1676–1677 (2007).
  • Fang X, Palanivel R, Zhou X et al. Hyperglycemia- and hyperinsulinemia-induced alteration of adiponectin receptor expression and adiponectin effects in L6 myoblasts. J. Mol. Endocrinol.35(3), 465–476 (2005).
  • Patel SB, Reams GP, Spear RM, Freeman RH, Villarreal D. Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease. Curr. Hypertens. Rep.10(2), 131–137 (2008).
  • Dong F, Ren J. Fitness or fatness – the debate continues for the role of leptin in obesity-associated heart dysfunction. Curr. Diabetes Rev.3(3), 159–164 (2007).
  • Yang R, Barouch LA. Leptin signaling and obesity: cardiovascular consequences. Circ. Res.101(6), 545–559 (2007).
  • Mark AL, Correia ML, Rahmouni K, Haynes WG. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J. Hypertens.20(7), 1245–1250 (2002).
  • Unger RH. Hyperleptinemia: protecting the heart from lipid overload. Hypertension45(6), 1031–1034 (2005).
  • Braunwald E. Biomarkers in heart failure. N. Engl. J. Med.358(20), 2148–2159 (2008).
  • Allison M. Is personalized medicine finally arriving? Nat. Biotechnol.26(5), 509–517 (2008).
  • Hamad E, Mather PJ, Srinivasan S, Rubin S, Whellan DJ, Feldman AM. Pharmacologic therapy of chronic heart failure. Am. J. Cardiovasc. Drugs7(4), 235–248 (2007).
  • Mao X, Hong JY, Dong LQ. The adiponectin signaling pathway as a novel pharmacological target. Mini Rev. Med. Chem.6(12), 1331–1340 (2006).
  • Patel AN, Genovese JA. Stem cell therapy for the treatment of heart failure. Curr. Opin. Cardiol.22(5), 464–470 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.